Trivitron Healthcare: Providing Cutting-Edge Healthcare Technology

Trivitron Healthcare| Chandra Ganjoo
Ms. Chandra Ganjoo | Executive Director | Group CPO and Head Corporate Communications

Medical IT companies are changing the landscape of the healthcare industry. They offer software and technology for medical practices, hospitals, and healthcare facilities to make day-to-day activities more efficient and secure.

Since 1997, the journey of Trivitron Healthcare as a medical technology company providing affordable healthcare solutions weaves a fascinating thread of inspiration to many healthcare providers. Trivitron markets its products to hospitals, individual healthcare providers, independent clinics and laboratories, extended care facilities, renal care centres, and all other roofs providing healthcare solutions. As a pioneer in the field, Trivitron constantly pursues technological innovations to offer superior clinical benefits at a lower cost. At Trivitron, quality healthcare is considered as a fundamental right and the vision is to make it available for people of all classes. Having solid expertise in research and development, Trivitron manufactures and distributes exceptional medical technology products to 180 countries.

Their core values are Self-Discipline, Passion and Determination, Integrity, Customer-Centric, Teamwork, Continuous Improvement. Their vision is to be the largest, most respected, and admired Medical Technology Company of Indian origin with a global presence promoting cost-effective medical technology products and services. And their mission is to innovate and provide Medical Technology Products, Services, and Solutions to make healthcare affordable and accessible to everyone across the globe.

Let us get into more of the dynamics of Trivitron through the below highlights of the interview by Ms. Chandra Ganjoo, Executive Director – Group CPO and Head Corporate Communications:

What makes your company a preferred choice over your competitors? List the products and your expertise that you want to highlight in this article.

Trivitron offers solutions and services in cardiology and implantable devices, imaging diagnostics, laboratory diagnostics, radiology, critical care and operating room equipment. It offers a complete range of medical equipment portfolios to equip Healthcare Institutions with the latest and best technology products.

At Trivitron, we are contributing to the global fight against the coronavirus through our products and expertise in medical technology and healthcare. In our fight against COVID-19, we at Trivitron have been working extensively to bring out solutions for COVID-19 testing, ICU solutions, and personal protection products.

Few products are as follows:

COVID-19 Testing Kits

Personal Protection Product

Ventilators

ICU Solutions

Virtual Dissection Table

Newborn Screening

Mammography

Radiography & C-Arm System

Ultrasound

Radiation Protection Products etc.

Being in a leadership position, what is your opinion on the impact of the current pandemic on the healthcare industry and the related HealthTech market?

The Covid-19 situation has severely impacted several business verticals, healthcare being the one under enormous strain. It has become challenging for other healthcare services to keep their financial wheels turning during the lockdown period due to less revenue churn and the general uncertainty in the global financial environment.

In these testing times, business leaders have adapted to a new set of rules and have been mindful of various business aspects to alleviate risks and to survive the slowdown caused by the impact of COVID19. To ensure business continuity, businesses are keeping a track of expenses against revenue status in a more detailed manner to have a clear picture of the financial status of the organization and thus plan future goals and business approach. Secondly, business leaders are digging deeper into the existing supply chains to know the vulnerabilities of the existing supply model and available supplier options that can be collaborated, once the primary supplier collapses. And most importantly, organizations are now setting more effective communication channels so that they remain connected with teams, clients, and all other business partners.

What kind of challenges has your company faced being in the medical devices business?

The Covid-19 situation has severely impacted several business verticals, healthcare being the one under enormous strain. It has become challenging for other healthcare services to keep their financial wheels turning during the lockdown period due to less revenue churn and the general uncertainty in the global financial environment.

In these testing times, business leaders have adapted to a new set of rules and have been mindful of various business aspects to alleviate risks and to survive the slowdown caused by the impact of COVID19. To ensure business continuity, businesses are keeping a track of expenses against revenue status in a more detailed manner to have a clear picture of the financial status of the organization and thus plan future goals and business approach. Secondly, business leaders are digging deeper into the existing supply chains to know the vulnerabilities of the existing supply model and available supplier options that can be collaborated, once the primary supplier collapses. And most importantly, organizations are now setting more effective communication channels so that they remain connected with teams, clients, and all other business partners.

Being in the medical devices space, how necessary do you think it is to align one’s business with the latest technological developments?

Healthcare changes dramatically because of technological developments. Future technological innovation is going to keep transforming healthcare, yet while technologies will drive innovation, human factors will remain one of the stable limitations of breakthroughs.

As one of the prominent medical device enablers, what steps have you taken towards tackling the COVID-19 pandemic and its impact, all the while safeguarding your employees and taking care of your clientele’s needs?

As a health technology organization, Trivitron has developed rigorous contingency plans to slow the progress of a pandemic and limit its impact on employees, partners, consumers, and communities. We are exploring our shortcomings and framing up new SOPs, Work Instructions, and guidelines that would support business continuity in case of a pandemic or a similar situation. Keeping in mind the still-evolving healthcare system of our country, Trivitron Healthcare has scaled-up production to yield more COVID-19 centric products. Trivitron has been a flag bearer of Make in India and has been working to manufacture COVID-19 related products in its manufacturing facilities in Chennai, Mumbai & Visakhapatnam. Trivitron Healthcare has in collaboration with its overseas partners, making an available range of Covid-19 RT PCR Test Kits, RNA Extraction Kits, Specimen collection Kits, COVID-19 antibody test kits, PCR systems, and other laboratory products, for COVID-19 diagnosis & confirmation.

Trivitron has been working with Manufacturer Ventilators to fulfill the demands of the current healthcare ecosystem. Further to this, Trivitron has also introduced hand sanitizing products, personal protection equipment (PPE), and other required modalities for COVID.

What advice would you like to give to the young entrepreneurs who are looking to enter the medical devices and healthcare space?

The year 2020, being the year of the pandemic, has served as a lesson for all. Business leaders and healthcare policymakers, in a post-pandemic world, shall adopt a new set of rules, confirm flexible guidelines, and remain careful to keep away from any risk-averse mode.

Self-sufficiency in medical technology will continue to grow driven by an increase in the demand for locally produced goods. Looking at the pace of technological advancements and the induction of new-age technologies, I am sure, we will be able to improve our logistics infrastructure, strengthen our manufacturing sector, and be able to develop our own forecasting systems that will further accelerate the Indian healthcare sector.

How do you envision sustaining your company’s competency in this ever-cutthroat business ecosystem? Where do you see your company in the next five years?

Today, Trivitron Healthcare is a market leader in providing cutting-edge health technology products which includes a range of diagnostic kits, analysers, laboratory equipment, radio diagnostic instruments, radiology lab consumables, and radiation protection apparel. In terms of market share, we are seeing considerable growth every fiscal.

We are working on an intensified growth strategy to expand our footprints in emerging global markets and plan to acquire more businesses internationally as well as in India. We are the pioneers of Newborn Screening technologies and have introduced in the market, an entire portfolio of NBS kits, analysers, laboratory consumables, workstations, equipment, etc. Our NBS product range is gaining global recognition and in the near future, we are poised to become an undisputed leader in NBS technologies.

Similarly, we have gained considerable momentum in ICU and critical care product segments. We are greatly recognized for the best-quality radiation protection modalities in South Asia. Given the trust of our customers and the acceptance that we are receiving, I am sure we will emerge as a global leader in radiation protection collaterals.

Going public is aligned with our plan to create value for investors as well as for our employees. Hopefully, we should be a listed company soon in a couple of years.

According to you, how does the future of medical devices and care systems look post-pandemic?

Taking cues from 2020, it shall be wise for organizations, to ensure business community, maintain a healthy balance sheet and keep a more detailed track of expenses against revenue status to have a clear picture of the financial status of the organization and accordingly plan future goals.

Secondly, business leaders need to dig deeper into the existing supply chains to know the vulnerabilities of the existing supply chain models and look for options to collaborate to keep supply chains functional once the primary supplier collapses. And most importantly, organizations must develop more effective communication channels to remain connected with teams, clients, and all other business partners.